Ballentine Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363K Sell
1,724
-562
-25% -$120K ﹤0.01% 697
2026
Q1
$506K Buy
2,286
+950
+71% +$232K 0.01% 528
2025
Q4
$339K Buy
1,336
+26
+2% +$6.53K ﹤0.01% 665
2025
Q3
$324K Buy
1,310
+28
+2% +$6.7K ﹤0.01% 682
2025
Q2
$308K Buy
1,282
+102
+9% +$23.7K ﹤0.01% 677
2025
Q1
$267K Buy
+1,180
New +$260K ﹤0.01% 668
2024
Q4
Sell
-879
Closed -$213K 942
2024
Q3
$213K Sell
879
-49
-5% -$11.5K ﹤0.01% 733
2024
Q2
$204K Buy
+928
New +$202K ﹤0.01% 691

Other funds holding STE

Ballentine Partners's STE Position: Q2 2026 in Review

Ballentine Partners reduced its Steris (STE) stake by 25% in Q2 2026, selling an estimated $120K and leaving 1,724 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Ballentine Partners first reported a position in STE in Q2 2024 and has held it in 8 quarters since. The position peaked at $506K in Q1 2026. 93 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Ballentine Partners held 1,724 shares of Steris worth $363K as of Q2 2026.
  • Ballentine Partners sold 562 Steris shares in Q2 2026, an estimated $120K.
  • Steris made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #697 holding.
  • Ballentine Partners first reported a position in Steris in Q2 2024 and has held it in 8 quarters since.
  • Ballentine Partners's Steris position peaked at $506K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.